1099:HKG
Sinopharm Group Co Ltd
HK$15.65
arrow_upward
+0.32%(+0.050) 1H
15 Okt, 4:08:33 PTG GMT+8 · HKD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk 1099...
Buka
HK$15.60
Tinggi
HK$15.77
Rendah
HK$15.50
Permodalan Pasaran
48.84B
Purata volum
4.77J
Volum
8.26J
Dividen
5.05%
Dividen suku tahunan
HK$0.20
Tarikh tanpa dividen
23 Jun 2026
Nisbah H/P
5.87
tgi 52 mgu
HK$22.34
rdh 52 mgu
HK$14.55
EPS
HK$2.67
Syer tertunggak
1.19B
Bilangan pekerja
90K
Buka
HK$15.60
Tinggi
HK$15.77
Rendah
HK$15.50
Permodalan Pasaran
48.84B
Purata volum
4.77J
Volum
8.26J
Dividen
5.05%
Dividen suku tahunan
HK$0.20
Tarikh tanpa dividen
23 Jun 2026
Nisbah H/P
5.87
tgi 52 mgu
HK$22.34
rdh 52 mgu
HK$14.55
EPS
HK$2.67
Syer tertunggak
1.19B
Bilangan pekerja
90K
Cerita berita
Daripada sumber web dan rakan kongsi berita
ad-hoc-news.de
·
5 jam lalu
HKD 16.95 average target for Sinopharm stock from 14 ratings
Profil
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Perihal Sinopharm Group Co Ltd